Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer - CORE1 (COlon Cancer REcurrence in Stage 1)

NCT05726188 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT05726188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer - CORE1 (COlon Cancer REcurrence in Stage 1)
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
September 30, 2023
Enrollment
2,000 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, colon cancer stage i